Protein arginine methyltransferase 5 is a key regulator of the MYCN oncoprotein in neuroblastoma cells-Reference-Cited by-同舟云学术

Protein arginine methyltransferase 5 is a key regulator of the MYCN oncoprotein in neuroblastoma cells

Published:2014-11-15 Issue:3 Volume:9 Page:617-627
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:

Author:

Park Ji Hyun,Szemes Marianna,Vieira Gabriella Cunha,Melegh Zsombor,Malik Sally,Heesom Kate J.,Von Wallwitz-Freitas Laura,Greenhough Alexander,Brown Keith W.,Zheng Y. George,Catchpoole Daniel,Deery Michael J.,Malik Karim

Funder

Cancer Research UK

The Showering Fund, North Bristol Health Trust, Bristol

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1016/j.molonc.2014.10.015/fullpdf

Reference25 articles.

1. Small molecule inhibitors of aurora-a induce proteasomal degradation of N-myc in childhood neuroblastoma;Brockmann;Cancer Cell,2013

2. Neuroblastoma: biological insights into a clinical enigma;Brodeur;Nat. Rev. Cancer,2003

3. Can archival tissue reveal answers to modern research questions?: computer-aided histological assessment of neuroblastoma tumours collected over 60 years;Chetcuti;Microarrays,2014

4. Arginine methylation controls growth regulation by E2F-1;Cho;EMBO J,2012

5. Protein arginine methyltransferase 5 inhibition induces lymphoma cell death through reactivation of the retinoblastoma tumor suppressor pathway and polycomb repressor complex 2 silencing;Chung;J. Biol. Chem,2013

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glutamine addiction is targetable via altering splicing of nutrient sensors and epitranscriptome regulators;2024-03-02

2. PRMT5 inhibition shows in vitro efficacy against H3K27M-altered diffuse midline glioma, but does not extend survival in vivo;Scientific Reports;2024-01-03

3. PRMT5 as a Potential Therapeutic Target in MYC-Amplified Medulloblastoma;Cancers;2023-12-15

4. MYCN and SNRPD3 cooperate to maintain a balance of alternative splicing events that drives neuroblastoma progression;Oncogene;2023-12-04

5. Epigenetic Dysregulation in MYCN-Amplified Neuroblastoma;International Journal of Molecular Sciences;2023-12-03